Clinical Trials Browser

Phase 2 × UNKNOWN × Erlotinib Hydrochloride × Clear all

NCT00600587 2013-06-25

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00663689 2008-04-22

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung